Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
+0.38%
SPX
+0.88%
IXIC
+1.31%
FTSE
+0.61%
N225
+1.03%
AXJO
+0.39%
Cashu Logo
⌘K
Log In
HomeWatchlistNewsSignals
Stocks
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Overview

Loading chart...

Key Stats

Market Cap
27.73M
Dividend Yield
0.00%
P/E Ratio
-1.23
EPS
-3.69
Revenue
678.00K
Avg. Volume
38.11K

Recently from Cashu

publisher logo
Cashu

Pluri's Innovative Developments and Future Prospects in Biotechnology.

about 1 month ago
publisher logo
Cashu

Pluri Stock Update: Key Developments and Insights for Investors

about 1 month ago
publisher logo
Cashu

Pluri Advances Cell Therapy, Transforming Regenerative Medicine for Degenerative Diseases

2 months ago

About

What does PLUR do?
Pluri, formerly Pluristem Therapeutics Inc., is an IL-based biotechnology company focused on cell-based products for pharmaceuticals, food technology, and agriculture, with over 140 patents across 52 countries. Their research includes cell transformation technologies and therapeutic programs for various medical conditions.
Sector
💻 Health Care
IPO
CEO
Employees
112
Headquarters
Israel
Website
http://www.pluristem.com
Join our newsletter to keep up to date with us!
Stocks
Health Care
plur
Pluri
NASDAQ: PLUR
-0.01 (-0.29%)
3.44
USD
At close at Dec 19, 21:39 UTC
Summary
News
Signals
Benchmarks
Financials